Market Inference Brief -- CNC Stock

Large-cap Health Care company Centene has logged a -2.1% change today on a trading volume of 310,097. The average volume for the stock is 3,260,825.

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. Based in Saint Louis, United States the company has 74,300 full time employees and a market cap of $36,939,698,176.

The company is now trading -16.36% away from its average analyst target price of $81.56 per share. The 16 analysts following the stock have set target prices ranging from $71.0 to $110.0, and on average give Centene a rating of buy.

Over the last 12 months CNC shares have declined by -20.0%, which represents a difference of -31.0% when compared to the S&P 500. The stock's 52 week high is $87.84 per share and its 52 week low is $60.83. Based on Centene's average net margin growth of 10.6% over the last 6 years, its core business remains strong and the stock price may recover in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2023 147,923,000 2,713,000 2 100.0
2022 144,547,000 1,202,000 1 0.0
2021 125,982,000 1,347,000 1 -50.0
2020 111,115,000 1,808,000 2 0.0
2019 74,639,000 1,321,000 2 100.0
2018 60,116,000 900,000 1
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.